CIBC Private Wealth Group
COLL icon

CIBC Private Wealth Group’s Collegium Pharmaceutical COLL Stock Holding History

CIBC Private Wealth Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$7.22K Sell
156
-93
-37% -$3.89K ﹤0.01% 2528
2025
Q3 		$8.71K Sell
249
-46
-16% -$1.6K ﹤0.01% 2429
2025
Q2 		$8.72K Buy
295
+46
+18% +$1.31K ﹤0.01% 2299
2025
Q1 		$6.33K Hold
249
– – ﹤0.01% 2391
2024
Q4 		$8.3K Hold
249
– – ﹤0.01% 2326
2024
Q3 		$9.62K Hold
249
– – ﹤0.01% 2416
2024
Q2 		$7.94K Hold
249
– – ﹤0.01% 2370
2024
Q1 		$9.68K Buy
+249
New +$8.71K ﹤0.01% 2290

Other funds holding COLL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return